|SEQ_NO||1||Date of announcement||2020/12/10||Time of announcement||14:30:24|
|Subject||Announcement of TTY Biopharm's unaudited income information in November 2020|
|Date of events||2020/12/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/12/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $313,221 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $45,971 thousands, and a consolidated income before tax of $50,423 thousands in November 2020; net income attributed to stockholders of the company was $39,167 thousands; EPS is $0.16.
Year-to-date consolidated net sales was $3,848,819 thousands (in NT dollars; unaudited), a consolidated operating profit was $878,667 thousands and consolidated income before tax was $1,041,379 thousands until November 2020; year-to-date net income attributed to stockholders of the company was $783,778 thousands; EPS is $3.15.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.